Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Connexin and gap junction degradation.

V M Berthoud1, P N Tadros, E C Beyer

  • 1Department of Pediatrics, University of Chicago, Chicago, Illinois 60637-1470, USA.

Methods (San Diego, Calif.)
|February 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The E368Q Mutant Allele of <i>GJA8</i> is Associated with Congenital Cataracts with Intrafamilial Variation in a South Indian Family.

Open access journal of ophthalmology·2017
Same author

Cardiac myocyte interconnections at gap junctions Role in normal and abnormal electrical conduction.

Trends in cardiovascular medicine·2011
Same author

A novel connexin50 mutation associated with congenital nuclear pulverulent cataracts.

Journal of medical genetics·2007
Same author

A novel GJA8 mutation is associated with autosomal dominant lamellar pulverulent cataract: further evidence for gap junction dysfunction in human cataract.

Journal of medical genetics·2006
Same author

Heteromeric mixing of connexins: compatibility of partners and functional consequences.

Cell communication & adhesion·2002
Same author

Functional role of the carboxyl terminal domain of human connexin 50 in gap junctional channels.

The Journal of membrane biology·2002
Same journal

Quantitative single-cell analysis of PML-RARα oncogene-induced DNA damage along cell cycle progression.

Methods (San Diego, Calif.)·2026
Same journal

Cilia SubQ: a modular suite of semi- and fully automated pipelines for analysis of primary cilia and ciliary subdomains.

Methods (San Diego, Calif.)·2026
Same journal

Projective invariant of surface ratio: application to pupil measurement through simulations and proof-of-concept recordings.

Methods (San Diego, Calif.)·2026
Same journal

A quantitative radiographic framework for longitudinal monitoring of additively manufactured biodegradable scaffolds with graded tantalum reinforcement.

Methods (San Diego, Calif.)·2026
Same journal

An accessible, absorbance-based plate reader assay to assess cumulative exposure of blood plasma & serum to thawed conditions.

Methods (San Diego, Calif.)·2026
Same journal

EC-isHCR: A rapid method for in situ hybridization chain reaction in diverse animal samples.

Methods (San Diego, Calif.)·2026
See all related articles

Connexin degradation pathways were studied using pharmacological inhibitors. Results show that connexin43 degradation involves both lysosomal and proteasomal proteolysis, impacting intercellular communication.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Gap junctions, formed by connexins, regulate intercellular communication.
  • Connexins are dynamic proteins with short half-lives, suggesting turnover is key to communication regulation.
  • Understanding connexin degradation is crucial for comprehending cellular communication control.

Purpose of the Study:

  • To develop and apply a pharmacological method for investigating connexin degradation pathways.
  • To elucidate the specific cellular mechanisms involved in connexin turnover.

Main Methods:

  • Utilized cell cultures treated with lysosomal or proteasomal proteolysis inhibitors.
  • Assessed changes in connexin levels and localization via immunoblotting and immunofluorescence.

Related Experiment Videos

  • Determined connexin decay curves using pulse-chase experiments and immunoprecipitation.

    • Main Results:

    • Demonstrated that connexin43 degradation is a dual process.
    • Provided evidence for the involvement of both lysosomal and proteasomal pathways in connexin43 breakdown.
    • Quantified connexin decay rates under different proteolysis inhibition conditions.

    Conclusions:

    • Connexin degradation is regulated by both lysosomal and proteasomal systems.
    • Pharmacological inhibition of proteolysis pathways offers insights into connexin turnover.
    • These findings highlight the dynamic nature of gap junctions and their regulation.